• 1
    ASBMR 2006 Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. American Society for Bone and Mineral Research, Washington, DC, USA.
  • 2
    Karaplis AC, Goltzman D 2000 PTH and PTHrP effects on the skeleton. Rev Endocr Metab Disord 1: 331341.
  • 3
    Goltzman D, White JH 2000 Developmental and tissue-specific regulation of parathyroid hormone (PTH)/PTH-related peptide receptor gene expression. Crit Rev Eukaryot Gene Expr 10: 135149.
  • 4
    Lanske B, Divieti P, Kovacs CS, Pirro A, Landis WJ, Krane SM, Bringhurst FR, Kronenberg HM 1998 The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology 139: 51945204.
  • 5
    Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345357.
  • 6
    Wennberg C, Hessle L, Lundberg P, Mauro S, Narisawa S, Lerner UH, Millan JL 2000 Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 15: 18791888.
  • 7
    Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G 2005 Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19: 10931104.
  • 8
    Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR, Whyte MP 1999 Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14: 20152026.
  • 9
    Krishnan V, Bryant HU, MacDougald OA 2006 Regulation of bone mass by Wnt signaling. J Clin Invest 116: 12021209.
  • 10
    Bezooijen RLV, Dijke PT, Papapoulos SE, Lowik CW 2005 SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev 16: 319327.
  • 11
    Moffatt P, Salois P, Gaumond MH, St-Amant N, Godin E, Lanctot C 2002 Engineered viruses to select genes encoding secreted and membrane-bound proteins in mammalian cells. Nucleic Acids Res 30: 42854294.
  • 12
    Evans SS, Collea RP, Leasure JA, Lee DB 1993 IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J Immunol 150: 736747.
  • 13
    Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM 1991 Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 199: 417423.
  • 14
    Yang G, Xu Y, Chen X, Hu G 2007 IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene 26: 594603.
  • 15
    Lange UC, Saitou M, Western PS, Barton SC, Surani MA 2003 The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol 3: 111.
  • 16
    Tanaka SS, Yamaguchi YL, Tsoi B, Lickert H, Tam PP 2005 IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev Cell 9: 745756.
  • 17
    Saitou M, Barton SC, Surani MA 2002 A molecular programme for the specification of germ cell fate in mice. Nature 418: 293300.
  • 18
    Moffatt P, Salois P, St-Amant N, Gaumond M-H, Lanctot C 2004 Identification of a conserved cluster of skin-specific genes encoding secreted proteins. Gene 334: 123131.
  • 19
    Moffatt P, Smith CE, Sooknanan R, St-Arnaud R, Nanci A 2006 Identification of secreted and membrane proteins in the rat incisor enamel organ using a signal-trap screening approach. Eur J Oral Sci 114(Suppl 1): 139146.
  • 20
    Smith CE, Nanci A, Moffatt P 2006 Evidence by signal peptide trap technology for the expression of carbonic anhydrase 6 in rat incisor enamel organs. Eur J Oral Sci 114(Suppl 1): 147153.
  • 21
    Thomas G, Moffatt P, Salois P, Gaumond MH, Gingras R, Godin E, Miao D, Goltzman D, Lanctot C 2003 Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J Biol Chem 278: 5056350571.
  • 22
    Krogh A, Larsson B, von Heijne G, Sonnhammer ELL 2001 Predicting transmembrane protein topology with a hidden markov model: Application to complete genomes. J Mol Biol 305: 567580.
  • 23
    Moffatt P, Thomas G, Sellin K, Bessette MC, Lafreniere F, Akhouayri O, St-Arnaud R, Lanctot C 2007 Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth. J Biol Chem 282: 3645436462.
  • 24
    Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, O'Loughlin PD, Morris HA 2007 Metabolism of vitamin D3 in human osteoblasts: Evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone 40: 15171528.
  • 25
    Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC 2003 RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18: 10881098.
  • 26
    de Oliveira PT, Zalzal SF, Irie K, Nanci A 2003 Early expression of bone matrix proteins in osteogenic cell cultures. J Histochem Cytochem 51: 633641.
  • 27
    Lanctot C, Lamolet B, Drouin J 1997 The bicoid-related homeoprotein Ptx1 defines the most anterior domain of the embryo and differentiates posterior from anterior lateral mesoderm. Development 124: 28072817.
  • 28
    Arana-Chavez VE, Nanci A 2001 High-resolution immunocytochemistry of noncollagenous matrix proteins in rat mandibles processed with microwave irradiation. J Histochem Cytochem 49: 10991109.
  • 29
    Wazen RM, Moffatt P, Zalzal SF, Daniel NG, Westerman KA, Nanci A 2006 Local gene transfer to calcified tissue cells using prolonged infusion of a lentiviral vector. Gene Therapy 13: 15951602.
  • 30
    Nielsen H, Engelbrecht J, Brunak S, von Heijne G 1997 Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 10: 16.
  • 31
    Baird JW, Ryan KM, Hayes I, Hampson L, Heyworth CM, Clark A, Wootton M, Ansell JD, Menzel U, Hole N, Graham GJ 2001 Differentiating embryonal stem cells are a rich source of haemopoietic gene products and suggest erythroid preconditioning of primitive haemopoietic stem cells. J Biol Chem 276: 91899198.
  • 32
    Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT 1999 Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14: 893903.
  • 33
    Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ 1995 Rapidly Forming Apatitic Mineral in an Osteoblastic Cell Line (UMR 106-01 BSP). J Biol Chem 270: 94209428.
  • 34
    Baron R, Rawadi G 2007 Targeting the Wnt/{beta}-catenin Pathway to Regulate Bone Formation in the Adult Skeleton. Endocrinology 148: 26352643.
  • 35
    Chan A, van Bezooijen RL, Lowik CW 2007 A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists. Curr Opin Investig Drugs 8: 293298.
  • 36
    Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747754.
  • 37
    Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 1729.
  • 38
    Oldberg A, Franzen A, Heinegard D 1986 Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83: 88198823.
  • 39
    Poser JW, Esch FS, Ling NC, Price PA 1980 Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. J Biol Chem 255: 86858691.
  • 40
    Lian JB, Hauschka PV, Gallop PM 1978 Properties and biosynthesis of a vitamin K-dependent calcium binding protein in bone. Fed Proc 37: 26152620.
  • 41
    Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J 2001 Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68: 577589.
  • 42
    Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W 2001 Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10: 537543.
  • 43
    Hanagata N, Takemura T, Monkawa A, Ikoma T, Tanaka J 2007 Phenotype and gene expression pattern of osteoblast-like cells cultured on polystyrene and hydroxyapatite with pre-adsorbed type-I collagen. J Biomed Mater Res A I83: 362371.
  • 44
    Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, Hogenesch JB 2002 Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99: 44654470.
  • 45
    Muramatsu S, Wakabayashi M, Ohno T, Amano K, Ooishi R, Sugahara T, Shiojiri S, Tashiro K, Suzuki Y, Nishimura R, Kuhara S, Sugano S, Yoneda T, Matsuda A 2007 Functional Gene Screening System Identified TRPV4 as a Regulator of Chondrogenic Differentiation. J Biol Chem 282: 3215832167.
  • 46
    Agoston H, Khan S, James C, Gillespie JR, Serra R, Stanton L-A, Beier F 2007 C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and - independent pathways. BMC Dev Biol 7: 18.
  • 47
    Smith RA, Young J, Weis JJ, Weis JH 2006 Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun 7: 113121.
  • 48
    Domon S, Shimokawa H, Yamaguchi S, Soma K 2001 Temporal and spatial mRNA expression of bone sialoprotein and type I collagen during rodent tooth movement. Eur J Orthod 23: 339348.
  • 49
    Nagata T, Bellows CG, Kasugai S, Butler WT, Sodek J 1991 Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem J 274: 513520.
  • 50
    Zhou HY, Takita H, Fujisawa R, Mizuno M, Kuboki Y 1995 Stimulation by bone sialoprotein of calcification in osteoblast-like MC3T3-E1 cells. Calcif Tissue Int 56: 403407.
  • 51
    Gramsch B, Gabriel HD, Wiemann M, Grummer R, Winterhager E, Bingmann D, Schirrmacher K 2001 Enhancement of connexin 43 expression increases proliferation and differentiation of an osteoblast-like cell line. Exp Cell Res 264: 397407.
  • 52
    Gordon JAR, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA 2007 Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 41: 462473.
  • 53
    Selim AA, Abdelmagid SM, Kanaan RA, Smock SL, Owen TA, Popoff SN, Safadi FF 2003 Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro. Crit Rev Eukaryot Gene Expr 13: 265275.
  • 54
    Zhang X, Carpenter D, Bokui N, Soo C, Miao S, Truong T, Wu B, Chen I, Vastardis H, Tanizawa K, Kuroda S, Ting K 2003 Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development. J Bone Miner Res 18: 21262134.